Month: July 2023

                                                 Press release Lesquin, 10 July 2023, 8.00 am NACON CONFIRMS DAEDALIC ENTERNAINMENT RESTRUCTURATION Lesquin, July 10 2023. Following the official statement made by Daedalic Entertainment, NACON confirms a reorganization is taking place within its studio, which will from now on focus on its publishing activities. Daedalic has been developing this expertise for a long time and has all the required resources to ensure the publishing of a dozen of indie games per year. Its catalogue for the current fiscal year remains the same and is particularly solid. Reorganization is focused on the development team : approximatively 25 persons are involved in the process, besides some external contractors. The consequence of this shift is the cancellation of the second project based on The Lord of the Rings...

Figure 1 Part of a split section of drill core from hole 23-GL-01 showing massive sulphideFigure 2 Road cutting where new massive sulphide has been observed in bedrockTORONTO, July 10, 2023 (GLOBE NEWSWIRE) — Galantas Gold Corporation (TSX-V & AIM: GAL; OTCQX: GALKF) (“Galantas” or the “Company”) is pleased to announce the results of the first exploration drill hole at the Gairloch Project in Scotland. Drilling highlights:Cobalt and vanadium, which are part of the UK’s list of critical minerals1, have been discovered, in addition to other minerals that are important raw materials enabling the transition to clean energy, including copper, silver, titanium and zinc.Hole 23-GL-01 intersected 2.87% copper (Cu), 0.77 grams per tonne (g/t) gold (Au), 0.46% zinc (Zn), 0.03% cobalt (Co) and 7.52 g/t silver (Ag) over 17.90...

PARIS and CAMBRIDGE, Mass., July 10, 2023 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced a global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, for the investigational, potential first-in-class radioenhancer NBTXR3. NBTXR3 is currently being evaluated in several studies across solid tumor indications including NANORAY-312, a global Phase 3 pivotal study evaluating NBTXR3 for the treatment of patients with locally advanced head and neck cancer. NBTXR3 is also being evaluated for its potential as a systemic agent in combination...

LONDON and VANCOUVER, British Columbia, July 10, 2023 (GLOBE NEWSWIRE) — Mkango Resources Ltd (AIM / TSX-V:MKA) (the “Company” or “Mkango”), announces that CEO, William Dawes and President, Alexander Lemon, will provide a corporate update on the Company via the Share Talk platform on Thursday 13 July 2023 at 17:30 pm BST. Please register for the event via the following link: https://www.bigmarker.com/share-talk/Mkango-Corporate-update. Questions can be submitted pre-event or at any time during the live presentation. For further information, please contact:Mkango Resources LimitedWilliam DawesChief Executive Officerwill@mkango.ca Alexander LemonPresidentalex@mkango.ca Robert SewellChief Financial Officerrob@mkango.ca www.mkango.ca@MkangoResources Canada: +1 403 444 5979TavistockPR and IR AdviserJos Simson, Cath Drummondmkango@tavistock.co.uk...

JOINT PRESS RELEASE This is a joint press release by Beter Bed Holding (“Beter Bed Holding”, “BBH” or the “Company“) and 959 B.V. (the “Offeror“), a company controlled by Torqx Capital Partners (“Torqx“). This joint press release is issued pursuant to the provisions of Section 17, paragraph 1 of the European Market Abuse Regulation (596/2014), as well as Section 4, paragraphs 1 and 3, Section 5, paragraph 1 and Section 7, paragraph 4 of the Netherlands Decree in Public Takeover Bids (Besluit openbare biedingen Wft, the “Decree“) in connection with the intended recommended public offer by the Offeror for all the issued and outstanding shares in the capital of the Company (the “Offer”). This press release does not constitute an offer, or any solicitation of any offer, to buy or...

 INSIDE INFORMATIONAgreement with the main creditors of BioSenic for a standstill running until October 2023 Mont-Saint-Guibert, Belgium, July 10th, 2023, 7.00 am CEST – BIOSENIC (Euronext Brussels and Paris: BIOS), the innovative company addressing unmet medical needs in the areas of innate immunity, inflammation and organ/function repair, today announces a further update on its financial arrangements with its main historical creditors, Patronale, Monument and the European Investment Bank. BioSenic aims at renegotiating its main financial debts, inherited from Bone Therapeutics. This is required for BioSenic to successfully launch a new fundraising, in the form of a private placement in Q 3-4 2023. For the debt renegotiation, our mediator, Yves Brulard, has achieved a standstill agreement from the main historical creditors for a...

Belships has entered into an agreement to divest its 100 per cent shareholding in Belships Management (Singapore) Pte Ltd., a technical and crew management company established in 1983, which currently manages dry bulk vessels for Belships ASA and other international clients. The shares have been acquired by a company in V.Group. An owned office lease in Singapore is in process of being sold, and the proceeds will be received by Belships ASA. Closing of the transaction was completed on 30th June 2023, and a book gain of USD 8.5m will be recorded in Q2 2023. Net cash proceeds will be about USD 12.5m and includes deferred payment for the office. Furthermore, Belships has entered into a strategic partnership with V.Group for Belships’ fleet and ship management business. Following the acquisition by V.Group, Belships Management (Singapore)...